The Association for the Advancement of Medical Instrumentation (AAMI) is reporting that the Food and Drug Administration (FDA) is inviting manufacturers to participate in a pilot program to assess the qualification process for tools used to develop medical devices.
The Medical Device Development Tools (MDDT) program is part of a broader effort by the agency to improve the efficiency and transparency of its review process for premarket applications. Tools include clinical outcome assessments, biomarker tests, and nonclinical assessment methods that ultimately can be used by industry in device submissions. Once a tool is qualified-determined in part by its “context of use” and purpose-device developers would be able to use it without regulators needing to reconfirm the suitability of the tool for each submission.
“MDDT tools qualified by FDA can then be relied upon by the medical device industry in support of their device submissions to the agency, potentially reducing time and other resources needed to develop new products,” according to an Aug. 15, 2014 Federal Register notice.
To read further from AAMI, CLICK HERE.
Source: AAMI
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.